China’s Humanoid Robot Boom is Running into an IPO Reality Check

Chinese regulators are slowing a rush of humanoid-robot companies seeking stock-market listings as they scrutinise whether soaring valuations and revenue linked to state-backed projects reflect sustainable commercial demand, people familiar with the matter said.

The move follows a volatile debut by Unitree Robotics, a maker of humanoid and quadruped robots. Its shares surged more than fivefold on their Shanghai debut last month before falling 55% from their peak, sharpening scrutiny of the sector’s valuations.

Regulators have used informal “window guidance” to hold back some humanoid-robot listings, the people said, requesting anonymity because of the sensitivity of the matter.

One person said humanoid IPOs had effectively been frozen for now, while another said there was no formal ban and described the move as a sector-specific slowdown.

The regulatory scrutiny reflects Beijing’s effort to temper investor enthusiasm for one of China’s hottest investment themes while continuing to promote humanoid robotics as a strategic technology.

The Information first reported, citing people with knowledge of the matter, that the CSRC had recently given informal guidance to some investment banks and investment firms that it was raising the bar for approving humanoid-robot IPOs.

Leo Wang, a venture capitalist at Qianchuang Capital, described the investment wave in robotics as “campaign-style innovation”, using a Chinese phrase for booms in which companies and capital rush into a policy-favoured sector.

Beijing has promoted “embodied intelligence” — AI systems capable of perceiving and acting in the physical world — as a strategic emerging industry, helping fuel investment by private capital and local governments.

Wang said hype around embodied AI had exceeded that seen during China’s internet and new-energy investment waves, with industrial-robot makers pivoting towards humanoids and startups commanding rapidly rising valuations.

Some founders were attracting dozens of prospective investors within weeks and refusing conventional due diligence, he said. Some private-market projects had already suffered valuation cuts of 30% to 50%.

At least half a dozen Chinese humanoid robotics firms are preparing to go public, including Deep Robotics, X Square Robot and AGIBOT. The three companies did not respond to Reuters’ requests for comment on whether regulators have slowed their plans.

Regulators are particularly focused on whether revenue generated by robotics companies through local-government-backed projects can be sustained, according to one person close to humanoid-robot investors.

The person said robot data-collection centres, where robots are trained, and joint ventures in which local governments could provide 80% to 90% of initial investment had generated significant revenue for some companies.

Such projects can provide orders that support private-market valuations and help companies meet listing thresholds, but regulators are questioning whether they represent demand from independent customers.

The person estimated that valuations at some robot companies could fall 60% to 70% if revenue associated with data-collection centres were stripped away.

Questions over the quality of revenue have been accompanied by uncertainty over what customers are actually buying.

Mech-Mind Robotics CEO Shao Tianlan alleged in a WeChat post this month that some highly valued embodied-AI firms were generating revenue through data-collection centres, related-party deals and other unsustainable arrangements as they raced towards IPOs.

Shares in Mech-Mind have fallen nearly 20% from their debut-day high on Sept. 1.

The tighter regulatory stance does not signal Beijing’s retreat from humanoid robotics, executives and investors said. Instead, it reflects a growing emphasis on deployment, order volumes and evidence that companies can turn technical demonstrations into commercially viable products, they said.

Ruiying Zhao, a senior research analyst at S&P Global Market Intelligence, said investor sentiment was shifting from “blanket euphoria to selective rationality”, with greater scrutiny of whether realised commercial value justified premiums.

The caution comes as fundraising by mainland Chinese companies rebounds. They have raised $148.9 billion through share sales and convertible offerings so far in 2026, up 59% from the same period a year earlier, according to LSEG data. Technology companies accounted for 41% of the total.

A senior banker involved in Asian equity offerings said investors were still willing to finance robotics companies but were becoming more demanding about deployment, volumes and valuation.

“What’s the use case? Is it just people’s robots dancing around? Is it working in factories?” the banker said. “The volume hasn’t really caught up with the hype.”

Stay ahead of the Stories shaping our world. Subscribe to Impact Newswire and join our 
WhatsApp Channel for updates on global tech, business, and innovation—all in one place.

Dive deeper into the future with the Cause Effect 4.0 Podcast, where we explore the ideas, trends, and technologies driving the global AI conversation.

Got a story to share? Contact Us to reach a global audience with Impact Newswire.